
Cingulate
A clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products.
Market cap
$21.3m
Enterprise value
$19m
Share price
$3.94 CING
Authorizing premium user...